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Abstract
Background: The treatment of coronary artery disease (CAD) seeks to reduce or prevent its complications and
decrease morbidity and mortality. For certain subgroups of patients, coronary artery bypass graft surgery (CABG)
may accomplish these goals. The objective of this study was to assess the pulmonary function in the CABG
postoperative period of patients treated with a physiotherapy protocol.
Methods: Forty-two volunteers with an average age of 63 ± 2 years were included and separated into three
groups: healthy volunteers (n = 09), patients with CAD (n = 9) and patients who underwent CABG (n = 20).
Patients from the CABG group received preoperative and postoperative evaluations on days 3, 6, 15 and 30.
Patients from the CAD group had evaluations on days 1 and 30 of the study, and the healthy volunteers were
evaluated on day 1. Pulmonary function was evaluated by measuring forced vital capacity (FVC), maximum
expiratory pressure (MEP) and Maximum inspiratory pressure (MIP).
Results: After CABG, there was a significant decrease in pulmonary function (p < 0.05), which was the worst on
postoperative day 3 and returned to the preoperative baseline on postoperative day 30.
Conclusion: Pulmonary function decreased after CABG. Pulmonary function was the worst on postoperative day 3
and began to improve on postoperative day 15. Pulmonary function returned to the preoperative baseline on
postoperative day 30.
Background
The treatment of coronary artery disease (CAD) seeks to
reduce or prevent its complications and decrease mor-
bidity and mortality. For certain subgroups of patients,
coronary artery bypass graft surgery (CABG) may
accomplish these goals [1].
Pulmonary dysfunction and associated complications
are the major cause of morbidity and mortality in the
period following cardiac CABG surgery [2]. The impair-
ment of pulmonary function has multiple causes, includ-
ing the use of a sternotomy, pleurotomy due to insertion
of the left internal thoracic artery [2], pleural drain inser-
tion [3], diaphragmatic dysfunction due to manipulation
of the viscera and reflex dysfunction of the phrenic nerve
caused by the use of cold cardioplegic solution [4,5].
Van Belle et al. analyzed the pulmonary function of 18
patients before surgery and in the first and sixth weeks
after CABG and concluded that respiratory muscle
weakness contributed to the decrease in function seen
in the first postoperative week. In another study with 37
patients who had undergone CABG, forced vital capacity
(FVC) decreased by 70% in the immediate postoperative
period and remained reduced in 35% of patients up to 3
weeks after surgery [6].
Many studies have shown the efficacy of physiother-
apy, such as incentive spirometry [7] and respiratory
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muscle training [8], in minimizing pulmonary dysfunc-
tion during the preoperative and postoperative periods.
However, these studies do not describe the effects on
pulmonary dysfunction, especially volume reduction and
respiratory muscle strength, over a sufficient period of
time. Therefore, the present study aims to evaluate the
effect of physiotherapy during cardiac rehabilitation
phase I on pulmonary function in patients who under-
went CABG.
Patients and methods
This longitudinal study included 42 subjects aged 48 to
78 years. Subjects were divided into the following three
groups: patients who underwent CABG, patients with
coronary artery disease (CAD) and healthy volunteers
(HV). The CABG and CAD groups were recruited at
the Hospital de Cardiologia Procordis.
Inclusion criteria
We Included for the study were, all candidates for
elective coronary artery bypass graft surgery, were
recruited and evaluated from January to 1999 to Janu-
ary to 2000, age 40 to 80 years and written informed
consent and the study was approved by the institu-
tional ethics committee (Resolution 196/96 of the
National Health Council). The three groups were
paired by age and gender. The patients included in the
CAD and CABG groups were also paired in relation to
the number of diseased blood vessels, verified by per-
cutaneous coronary angiography (obstruction≥ 50%).
All of the subjects from the CAD group had been pre-
viously recommended for CABG but instead chose
medical treatment.
Exclusion criteria
We excluded patients who had a history of previous car-
diac surgery, diabetes mellitus, pacemaker implantation,
atrial fibrillation, chronic heart failure, utilization of
intra-aortic balloon pump, mechanical ventilation longer
than 24 hours, acute myocardial infarction within 6
months prior to the surgery, autonomic neuropathy and
pulmonary disease.
Protocol
All the subjects in the CABG group had a preoperative
evaluation and orientation in accordance to the phy-
siotherapy procedures. After surgery, they had phy-
siotherapy sessions twice a day for 30 minutes up to
postoperative day 6 or until discharge from the hospital
(Table 1).
After discharge, all groups received physiotherapy,
which included respiratory exercises and walking. They
were monitored for 30 days and were evaluated on the
following schedules: day 1 for the HV control group,
days 1 and 30 for the CAD group, and preoperation and
postoperative days 3, 6, 15 and 30 for the CABG group.
Ventilation test
The pulmonary function tests were performed to mea-
sure FVC were measured by spirometry (Spirodoc- Mir;
Rome, Italy). For the procedures, subjects sat with their
feet resting on the floor. They were asked to inhale dee-
ply to measure the total lung capacity (TLC) and to
strongly exhale into the spirometer’s mouthpiece to
measure the residual volume (RV). Three tests were per-
formed, and the best result was selected. The reference
values in the Guidelines for the Pulmonary Function
Testing were used for this study [9].
Maximum inspiratory pressure (MIP) and maximum
expiratory pressure (MEP) were measured with manu-
vacuometers (M120 healthcare; 2001; São Paulo, Brazil)
to verify static respiratory pressure. The manuvacu-
ometer mouthpiece has 2-mm holes that dissipate the
pressures generated by the facial muscles and the oro-
pharynx. To measure the MIP, individuals were
instructed to exhale up to the RV, inhale deeply with
the manuvacuometer’s mouthpiece (Müller’s maneu-
ver) in place and maintain the strain with their respira-
tory muscles for 3 seconds [10].
To measure the MEP, participants were instructed to
deeply inhale up to the TLC, do a forced exhalation
(Valsalva maneuver) and maintain the strain with their
respiratory muscles for 3 seconds.
Physiotherapy of protocol
On the day preceding surgery, patients received orien-
tation and training regarding the physiotherapeutic
procedures to be conducted in the postoperative per-
iod, such as re-expansion respiratory exercises, pursed
lips breathing, flow and volume incentive spirometry,
huffing, holding a cough pillow to the chest and con-
tinuous positive airway pressure (CPAP) by face mask.
In the first 12 hours after surgery, the subjects were
extubated, they received CPAP for 20 minutes and
Table 1 Physiotherapy protocol after extubation up to
postoperative day 6 or hospital discharge
PO day Physiotherapy protocol
1 CPAP with face mask for 20 minutes, reexpansion respiratory
exercises, pursed lips breathing, incentive spirometry, huffing,
coughing and transfer patient to an armchair
2 Same as PO day 1 walking around the patient’s room
3 and 4 Respiratory reexpansion exercises, pursed lips breathing,
incentive spirometry, a 60-meter walk and a walk down 17
stairs with the return upstairs using a lift (PO day 4)
5 and 6 Same as PO day 4, walk 120 meters and walk up a flight of
stairs.
PO = postoperative; CPAP = continuous positive airway pressure.
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they continued respiratory exercises, such as huffing
and directed coughing, from postoperative days 1 to 6
(Table 1).
Statistical analyses
Statistical analysis was performed in Statistica version
7.0 (Stasoft Corporation, Tulsa, USA). Sample size was
calculated and resulted in 10 patients, to achieve an
alpha error of 0.05 and power of 0.9. Two-way ANOVA
was used for repeated measures. The main factors were
time and groups (control, CABG and CAD). When dif-
ferences were found, the Bonferroni post-hoc analysis
was used, and p < 0.05 was considered statistically sig-
nificant. To compare anthropometric variables in the
three groups, single-factor ANOVA (group) was used.
Chi-square analysis was used to compare rates of medi-
cation use.
Results
FVC, MIP and MEP were all normal in the HV control
group (n = 13). The CAD group contained nine sub-
jects. For the CABG group, 20 patients were recruited
and 7 were excluded for the following reasons: diagnosis
of lung cancer, pneumonia, study withdrawal and death.
The 13 remaining patients (5 females and 8 males) had
an average age of 63 ± 2 years (Tables 2). The anes-
thetic drugs used in the CABG group during surgery
were pancuronium, propofol, fentanyl, midazolam and
diazepam.
At the first evaluation, there were no significant differ-
ences in FVC, MIP or MEP among the groups (p > 0.05)
(Figure 1). In the CABG group, there was a statistically
significant decrease in the FVC (p < 0.05) on postopera-
tive days 3 and 5. The biggest decrease was on
postoperative day 3, and lung function returned to the
preoperative level by postoperative day 15 (Figure 1).
The MIP significantly decreased (p < 0.05) in the
CABG group on postoperative days 3, 6 and 15 com-
pared to the preoperative MIP. The MIP returned to the
preoperative value by postoperative day 30 (Figure 1).
The MEP was significantly decreased (p < 0.05) on post-
operative days 3 and 6 and returned to the preoperative
baseline by postoperative day 15.
Discussion
Many factors have been suggested to be responsible for
the decrease in pulmonary function and consequently
FVC [1] and muscular strength after CABG. Some sug-
gested factors include anesthesia, analgesics, surgical
stress, pain [11], reduced ventricular function, phrenic
nerve injury, cardiovascular drugs, extracorporeal circu-
lation (EC) [12] and the position of the drains [13].
Pain due to thoracotomy is a limiting factor for mobi-
lity and breathing. A high level of postoperative pain is
common because of the cutting of the skin, muscles and
pleura as well as the retraction of muscles and liga-
ments, pleural and septal nerve irritation from thoracic
drains and occasional rib fractures [14].
Yung et al. [15] studied the analgesic effect of mor-
phine infusion via spinal catheter in 40 revascularized
patients. They found a significant reduction in pain,
respiratory insufficiency, extubation time and reintuba-
tion percentage compared to the control group.
Although analgesia is necessary for shortening mechani-
cal ventilation time and must be given during the first
few postoperative hours, analgesia in the postoperative
period interferes with pulmonary function. In this study,
the analgesic dosing was standardized (Table 2).
Table 2 Anthropometric, clinical and surgical characteristics of each group of subjects
Characteristics CABG (n = 13) CAD (n = 9) Control (n = 9)
Gender (male/female) 8/5 5/4 5/8
Age (years) 64 ± 2 64 ± 2 63 ± 2
BMI (kg/m2) 27.6 ± 0.6 27.4 ± 0.7 26.5 ± 0.9
Number of veins 3 ± 1 3 ± 1
Torrington and Henderson scale (points) 4 4
Extracorporeal circulation time (min) 85 ± 24
AC (min) 56 ± 18
TTOT (hours) Medications 4.2 ± 2.3
ACE inhibitors 5 6
Digitalis 3 0
Antiarrhythmic drugs 1 0
ASA 7 3
Calcium channel antagonists 4 1
CABG = coronary artery bypass graft; CAD = coronary artery disease; BMI = body mass index; AC = aortic clamping; ACE = angiotensin-converting enzyme; TTOT
= orotracheal intubation time; ASA = acetylsalicylic acid
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Pain may also contribute to decreased cough effi-
ciency, which is the main mechanism for the elimination
of secretions from the tracheobronchial tree due to the
immobility of the thoracic wall. This immobility causes
superficial breathing, which may result in atelectasis,
inadequate ventilation-perfusion ratio and pneumonia.
These complications lead to increased morbidity [13].
Our results showed a 33% decrease in pulmonary
function on postoperative day 3 and a 23% decrease on
postoperative day 6 compared to the preoperative per-
iod. These results are similar to the existing literature
on pulmonary function on postoperative day 6 ([16-20]).
In a study developed by Shernkman et al. with 37 sub-
jects who underwent CABG, there was a 70% decrease
in FVC immediately after surgery. FVC remained
reduced in 35% of subjects up to 3 weeks after surgery.
We can attribute this difference to the physiotherapy
that our subjects received up to postoperative day 6
[16].
Left ventricular dysfunction, which increases extravas-
cular fluid in the lungs, leading to altered lung compli-
ance and increased pulmonary resistance, may result in
increased respiratory work and oxygen consumption
[21,22].
Figure 1 Forced vital capacity, maximal inspiratory pressure and maximal expiratory pressure in the preoperative period and on
postoperative days 3, 6, 15 and 30. *p < 0.05 pre vs. days in CABG. FVC = forced vital capacity; MEP = maximal expiratory pressure; MIP =
maximal inspiratory pressure; CABG = coronary artery bypass graft; CAD = coronary artery disease; HV = healthy volunteers
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Phrenic nerve injury may also cause a reduction in
pulmonary function. Anatomically, the right phrenic
nerve travels between the pericardium and the mediast-
inal pleura, and the left phrenic nerve descends between
the subclavian artery and left common carotid lateral to
the vagus nerve and anterior to the left lung root. Pro-
posed mechanisms for phrenic nerve injury include
decreased nerve conductance due to the freezing of the
myocardium in the preoperative period for myocardial
preservation [17,22], reduced perfusion of the phrenic
nerve due to injury of the branches of the internal
mammary artery during dissection [21,23], trauma to
the phrenic nerve during sternotomy [24] and internal
jugular vein puncture [18,22].
Phrenic nerve injury during heart surgery has an inci-
dence of 26% [23] and may cause diaphragmatic paresis.
The right phrenic nerve is more commonly injured, and,
rarely, bilateral injury can occur [7].
Pulmonary function after CABG and physiotherapy
All patients undergoing CABG received physiotherapy
from before the operation up to postoperative day 6.
Haeffener et al. [25] demonstrated the efficacy of posi-
tive expiratory pressure (PEP) respiratory incentive
spirometry in preventing pulmonary complications
after heart surgery. Their sampling was composed of
34 patients who underwent CABG (PEP group, n = 17;
control group, n = 17). Their results were similar to
the results of this study in relation to the decrease in
pulmonary function in the PEP group. On postopera-
tive day 7 there was a significant decrease in FVC,
MIP, MEP and 6-minute walking test results, except
for subjects in the PEP group. Notably, the PEP group
had a lower rate of postoperative complications, such
as pneumonia.
Borghi-Silva et al. [18] investigated the effects of
respiratory physiotherapy with PEP incentive spirometry
on phase I cardiovascular rehabilitation, pulmonary
function and respiratory muscle strength after CABG. It
was concluded that cardiac surgery reduces pulmonary
function and the respiratory muscle strength, especially
on postoperative day 5. However, the combination of
physiotherapy and PEP incentive spirometry reduced
these complications. Although PEP incentive spirometry
is widely utilized in hospitals before and after CABG, its
acute effects on cardiovascular function are not yet clear
as the only data in this area are from healthy individuals
[26].
Herdy et al. [7] investigated the hypothesis that
respiratory physiotherapy might minimize adverse cardi-
opulmonary effects after CABG in 56 subjects (pulmon-
ary rehabilitation group, n = 29; control group, n = 27).
Pulmonary rehabilitation was started at least 5 days
prior to the surgery, and the protocol adopted, similar
to the one used by our group, included CPAP.
Subjects in the pulmonary rehabilitation group had
less mechanical ventilation time, atelectasis, pneumonia
and atrial fibrillation as well as a shorter hospitalization
time.
Various studies have confirmed that this therapeutic
modality contributes to decreased PaCO2, transpulmon-
ary pressure, respiratory work and hypoxemia and
increases pulmonary volumes, mainly FVC, to prevent
atelectasis [26,27]. For this reason we used CPAP in our
experimental protocol.
Recently, many studies have investigated the benefits
of respiratory muscle training [8,27] for postoperative
outcomes.
Hulzebos et al. [8] developed a randomized, experi-
mental protocol to analyze the inspiratory muscle train-
ing (IMT) efficiency for minimizing pulmonary
complications after CABG. Their study randomized 279
subjects to IMT (n = 140) or conventional treatment (n
= 139). Both groups received the same treatment after
surgery.
The protocol was started 10 weeks prior to surgery
with IMT being performed 7 times a week for 20 min-
utes each time. Six sessions were unsupervised, and one
was supervised. The protocol was initiated with 30% of
the MIP. The IMT group had fewer postoperative pul-
monary complications. It was concluded that IMT dur-
ing the preoperative period minimized pulmonary
complications after CABG.
Clinical implications
In this study, the alterations in pulmonary function and
respiratory muscle strength in subjects after undergoing
CABG demonstrate the need for early intervention in
the preoperative period with the goal of optimizing pul-
monary function. Physiotherapy, including incentive
spirometry, should be continued in the postoperative
period.
Limitations of the study
The present study should be interpreted in the light of
some limitations. First of all, the sample size was small.
Second, the intervention was carried out only during the
hospitalization period, and the same physiotherapy pro-
tocol was utilized for all patients. It must be emphasized
that for ethical reasons, it was not possible to have a
control group that did not receive treatment. Therefore,
this study is not intended to evaluate the effects of phy-
siotherapy on the decrease in pulmonary function after
CABG. However, we can infer that the treatment had a
positive effect because we observed a lower degree of
pulmonary dysfunction compared to that described in
the literature.
Third, the time interval among the evaluations was
relatively long, especially from postoperative days 6 to
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15 and 15 to 30. As a result, we were not able to accu-
rately define when pulmonary function returned to nor-
mal values.
Conclusion
Pulmonary function decreased after CABG. Pulmonary
function was the worst on postoperative day 3 and
began to improve on postoperative day 15. Pulmonary
function returned to the preoperative baseline on post-
operative day 30.
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